Bullish option flow detected in AXSOME with 4,244 calls trading, 1.2x expected, and implied vol increasing over 3 points to 82.72%. Jan-24 30 calls and Jan-23 110 calls are the most active options, with total volume in those strikes near 1,300 contracts. The Put/Call Ratio is 0.23. Earnings are expected on February 28th.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on AXSM:
- Axsome Therapeutics presents data on EVOLVE open-label trial of AUVELITY
- Axsome Therapeutics Presents New Data from the EVOLVE Open-Label Trial Demonstrating Effects of AUVELITY® on Cognitive and Physical Functioning in Patients with Major Depressive Disorder at the American College of Neuropsychopharmacology (ACNP) 2022 Annual Meeting
- Biotech Alert: Searches spiking for these stocks today
- Axsome Therapeutics price target raised to $86 from $73 at Morgan Stanley
- Axsome’s positive data may provide path for earlier sNDA filing, says Ladenburg